TQB-3911

N/A

Report date: 2025/01/22 15:59:36
NME

Base Information

Drug NameTQB-3911
Drug Alias NameTQB3911TQB-3911
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsLeukemia, Myelogenous, ChronicLeukemiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, ChronicLeukemia
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A